99mTc-labeled monosaccharide kits: development methods and quality control; Scientific Reports; Vol. 10
| Parent link: | Scientific Reports Vol. 10.— 2020.— [5121, 9 p.] |
|---|---|
| Corporate Author: | Национальный исследовательский Томский политехнический университет Физико-технический институт Лаборатория № 31 ядерного реактора |
| Other Authors: | Stasyuk (Stasiuk) E. S. Elena Sergeyevna, Skuridin V. S. Viktor Sergeyevich, Rogov A. S. Alexander Sergeyevich, Zelchan R. V. Roman Vladimirovich, Sadkin V. L. Vladimir Leonidovich, Varlamova N. V. Natalya Valeryevna, Nesterov E. A. Evgeny Alexandrovich |
| Summary: | Title screen The paper presents the procedure for planning an experiment to create standard sets of reagents for a technetium-99m generator based on glucose derivatives. All stages are presented from researching the required quantities of a substance, a reducing agent, a stabilizer and auxiliary components to developing lyophilized kits and conducting quality control. The radiochemical purity of radiopharmaceuticals prepared on the basis of the developed kits ranged from 90.0 to 99.0%. We also showed the functional suitability of the developed preparations on C57B1/6j mice with an implanted malignant tumor - Lewis lung carcinoma. |
| Language: | English |
| Published: |
2020
|
| Subjects: | |
| Online Access: | http://earchive.tpu.ru/handle/11683/65323 https://doi.org/10.1038/s41598-020-61707-7 |
| Format: | Electronic Book Chapter |
| KOHA link: | https://koha.lib.tpu.ru/cgi-bin/koha/opac-detail.pl?biblionumber=662005 |
Similar Items
99mTc-labeled nanocolloid drugs: development methods; Scientific Reports; Vol. 10, iss. 1
Published: (2020)
Published: (2020)
Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer; Pharmaceutics; Vol. 13, iss. 2
Published: (2021)
Published: (2021)
Cancer-Targeted Drug Delivery
Published: (2025)
Published: (2025)
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?; Pharmaceutics; Vol. 17, iss. 10
Published: (2025)
Published: (2025)
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8; Pharmaceutics; Vol. 17, iss. 8
Published: (2025)
Published: (2025)
Comparative Preclinical Evaluation of HYNIC-Modified Designed Ankyrin Repeat Proteins G3 for the 99mTc-Based Imaging of HER2-Expressing Malignant Tumors; Molecular Pharmaceutics; Vol. 21, iss. 4
Published: (2024)
Published: (2024)
Use of multi-angle ultra-wide band microwave sounding for high resolution breast imaging; Medical Physics; Vol. 47, iss.10
Published: (2020)
Published: (2020)
Heterodimeric Radiotracer Targeting PSMA and GRPR for Imaging of Prostate Cancer—Optimization of the Affinity towards PSMA by Linker Modification in Murine Model; Pharmaceutics; Vol. 12, iss. 7
Published: (2020)
Published: (2020)
Novel Chlorin with a HYNIC: Synthesis, 99mTc-Radiolabeling, and Initial Preclinical Evaluation; Molecules; Vol. 30, iss. 1
Published: (2025)
Published: (2025)
Direct Intra-Patient Comparison of Scaffold Protein-Based Tracers, [99mTc]Tc-ADAPT6 and [99mTc]Tc-(HE)3-G3, for Imaging of HER2-Positive Breast Cancer; Cancers; Vol. 15 - iss. 12
Published: (2023)
Published: (2023)
66Ga-PET-imaging of GRPR-expression in prostate cancer: production and characterization of [66Ga]Ga-NOTA-PEG2-RM26; Scientific Reports; Vol. 11, iss. 1
Published: (2021)
Published: (2021)
Investigation of the Size Distribution for Diffusion-Controlled Drug Release From Drug Delivery Systems of Various Geometries; Journal of Pharmaceutical Sciences; Vol. 108, iss. 8
by: Spiridonova T. I. Tatjyana Igorevna
Published: (2019)
by: Spiridonova T. I. Tatjyana Igorevna
Published: (2019)
Optimal composition and position of histidine-containing tags improves biodistribution of 99mTc-labeled DARPin G3; Scientific Reports; Vol. 9
Published: (2019)
Published: (2019)
A multi-level thresholding method for breast thermograms analysis using Dragonfly algorithm; Infrared Physics & Technology; Vol. 93
Published: (2019)
Published: (2019)
All-Optical Nanoscale Heating and Thermometry with Resonant Dielectric Nanoparticles for Controllable Drug Release in Living Cells; Laser & Photonics Reviews; Vol. 14, iss. 3
Published: (2020)
Published: (2020)
Porous Inorganic Carriers Based on Silica, Calcium Carbonate and Calcium Phosphate for Controlled/Modulated Drug Delivery: Fresh Outlook and Future Perspectives; Pharmaceutics; Vol. 10, iss. 4
Published: (2018)
Published: (2018)
Fabrication of MoO3/TiO2-SiO2 with hollow spherical shape using resin as the template: Effect of decomposition of resins; Journal of Applied Polymer Science; Vol. 138, iss. 34
Published: (2021)
Published: (2021)
Chitosan-collagen based film for controlled delivery of a combination of short life anesthetics; International Journal of Biological Macromolecules; Vol. 140
Published: (2019)
Published: (2019)
Comparison of HER2-targeted affibody conjugates loaded with auristatin- and maytansine-derived drugs; Journal of Controlled Release; Vol. 355
Published: (2023)
Published: (2023)
The Use of Glycine-Containing Peptide-Based Chelators for Labeling with 99mTc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1; Molecular Pharmaceutics; Vol. 23, iss. 4
Published: (2026)
Published: (2026)
Preclinical Evaluation of a Novel High-Affinity Radioligand [ 99mTc]Tc-BQ0413 Targeting Prostate-Specific Membrane Antigen (PSMA); International Journal of Molecular Sciences; Vol. 24 - iss.24
Published: (2023)
Published: (2023)
Silver Nanoparticles Targeting the Drug Resistance Problem of Streptococcus dysgalactiae: Susceptibility to Antibiotics and Efflux Effect; International Journal of Molecular Sciences; Vol. 23, iss. 11
Published: (2022)
Published: (2022)
Human Mesenchymal Stem Cells as a Carrier for a Cell-Mediated Drug Delivery; Frontiers in Bioengineering and Biotechnology; Vol. 10
Published: (2022)
Published: (2022)
Phase I Clinical Evaluation of Designed Ankyrin Repeat Protein [99mTc]Tc(CO)3-(HE)3-Ec1 for Visualization of EpCAM-Expressing Lung Cancer; Cancers; Vol. 16, iss. 16
Published: (2024)
Published: (2024)
Preclinical Evaluation of the Copper-64 Labeled GRPR-Antagonist RM26 in Comparison with the Cobalt-55 Labeled Counterpart for PET-Imaging of Prostate Cancer; Molecules; Vol. 25, iss. 24
Published: (2020)
Published: (2020)
New variants in the BRCA1 gene in Buryat Mongol breast cancer patients: Report from two families; Cancer Biomarkers; Vol. 18, iss. 5
Published: (2017)
Published: (2017)
Penetration Efficiency of Antitumor Agents in Ovarian Cancer Spheroids: The Case of Recombinant Targeted Toxin DARPin-LoPE and the Chemotherapy Drug, Doxorubicin; Pharmaceutics; Vol. 11, iss. 5
Published: (2019)
Published: (2019)
The first experience of using of {99}mTc-Al[2]O[3] for detection of sentinel lymph nodes in breast cancer; IOP Conference Series: Materials Science and Engineering; Vol. 135 : Issues of Physics and Technology in Science, Industry and Medicine
Published: (2016)
Published: (2016)
Single-Photon Emission Computer Tomography Imaging of Prostate-Specific Membrane Antigen (PSMA) Expression in Prostate Cancer Patients Using a Novel Peptide-Based Probe [99mTc]Tc-BQ0413 with Picomolar Affinity to PSMA: A Phase I/II Clinical Study; ACS Pharmacology & Translational Science; Vol. 8, iss. 3
Published: (2025)
Published: (2025)
Controlled drug release from electrospun PCL non-woven scaffolds via multi-layering and e-beam treatment; Materials Today Communications; Vol. 26
Published: (2021)
Published: (2021)
Dosimetric and radiobiological comparison of simultaneous integrated boost and sequential boost of locally advanced cervical cancer; Physica Medica; Vol. 73
Published: (2020)
Published: (2020)
Deep Learning for Cancer Diagnosis
Published: (2021)
Published: (2021)
Free-standing microchamber arrays as a biodegradable drug depot system for implant coatings; European Polymer Journal; Vol. 114
Published: (2019)
Published: (2019)
Smoking-related DNA adducts as potential diagnostic markers of lung cancer: new perspectives; Experimental Oncology; Vol. 37, № 1
Published: (2015)
Published: (2015)
Изучение адсорбции 99mTC на оксиде алюминия; Радиохимия; № 5
Published: (2011)
Published: (2011)
Peptide Blocking CTLA-4 and B7-1 Interaction; Molecules; Vol. 26, iss. 2
Published: (2021)
Published: (2021)
The position of 99mTc-HYNIC and the molecular design of the DARPin G3 constructs influence the selection of an imaging tracer to detect expression in HER2-expressing tumors; Journal of Radioanalytical and Nuclear Chemistry; Vol. 335
Published: (2026)
Published: (2026)
Информационная система хирургического кабинета; Информационные технологии в науке, управлении, социальной сфере и медицине; Ч. 2
by: Соколовский Д. Е.
Published: (2018)
by: Соколовский Д. Е.
Published: (2018)
Adsorption of 99mTc on aluminum oxide; Radiochemistry; Vol. 53, iss. 5
Published: (2011)
Published: (2011)
HER2-Specific Pseudomonas Exotoxin A PE25 Based Fusions: Influence of Targeting Domain on Target Binding, Toxicity, and In Vivo Biodistribution; Pharmaceutics; Vol. 12, iss. 4
Published: (2020)
Published: (2020)
Similar Items
-
99mTc-labeled nanocolloid drugs: development methods; Scientific Reports; Vol. 10, iss. 1
Published: (2020) -
Preclinical Evaluation of 99mTc-Labeled GRPR Antagonists maSSS/SES-PEG2-RM26 for Imaging of Prostate Cancer; Pharmaceutics; Vol. 13, iss. 2
Published: (2021) -
Cancer-Targeted Drug Delivery
Published: (2025) -
Phase I Clinical Study with the GRPR-Antagonist [99mTc]Tc-DB8 for SPECT Imaging of Prostate Cancer: Does the Injected Peptide Mass Make a Difference?; Pharmaceutics; Vol. 17, iss. 10
Published: (2025) -
The Impact of the Injected Mass of the Gastrin-Releasing Peptide Receptor Antagonist on Uptake in Breast Cancer: Lessons from a Phase I Trial of [99mTc]Tc-DB8; Pharmaceutics; Vol. 17, iss. 8
Published: (2025)